{"id":3679,"date":"2023-03-27T09:31:54","date_gmt":"2023-03-27T07:31:54","guid":{"rendered":"https:\/\/blogs.tu-braunschweig.de\/pubpharm\/?p=3679"},"modified":"2023-03-27T09:31:54","modified_gmt":"2023-03-27T07:31:54","slug":"results-of-the-user-survey-2022-part-1","status":"publish","type":"post","link":"https:\/\/blog.pubpharm.de\/index.php\/en\/2023\/03\/27\/results-of-the-user-survey-2022-part-1\/","title":{"rendered":"Results of the user survey 2022: Part 1"},"content":{"rendered":"

Feedback from the pharmaceutical research community supports the continuous optimisation and development of all services of the FID Pharmazie<\/a> and the PubPharm<\/a> research platform. An online survey<\/a> was conducted from July to September 2022 to specify user needs, identify potential services, and better understand user behaviour. Approximately 2,500 people from the 22 pharmacy universities in Germany were contacted via email and informed about the survey directly on PubPharm. In addition, the survey was advertised on the social media channels of the FID (PubPharm Blog<\/a>, Twitter<\/a>, LinkedIn<\/a>) and events attended during this period (e.g., the Annual Meeting of the Deutsche Pharmazeutische Gesellschaft<\/a> (DPhG)). Multipliers drew attention to this survey through their channels.<\/p>\n

The questionnaire, available in English and German, included three sections: general questions (e.g., about the field of activity), questions about literature\/information search (e.g., on the use of search tools and functions) according to the self-assessment of the participants into „PubPharm users“ (familiar with PubPham) and „PubPharm non-users“, questions on the innovative search tools developed at the Institute for Information Systems<\/a> (IfIS) (including the Narrative Service), and finally questions on the topic of research data management.<\/p>\n

155 persons participated in the survey, of which 117 (N) fully completed their questionnaire. The results were evaluated primarily based on the fully completed questionnaires. Percentages are rounded.<\/p>\n

The results are used for the further development of the FID Pharmazie and optimisation of the services. For this purpose, the comment fields of incomplete questionnaires were also evaluated.<\/p>\n

 <\/p>\n

Participants of the survey<\/h1>\n

68.4% of the participants belong to a university (where you can study pharmacy). The remaining persons are employed at other universities (17.1%), hospitals (5.1%), non-profit research institutions (4.3%), industry (2.6%), governmental\/federal labs (<1.0%), pharmacy shops (<1.0%) or other (<1.0%) (e.g., university hospital) (Fig. 1). PhD students form the largest group of participants with 39.3%, followed by research associates and (assistant) professors, who make up about 20.5% and 16.2% of the respondents, respectively (Fig. 2). Other participants include postdocs (9.4%), PhD with habilitation (3.4%), students (<1%) and, under the category of others (10.3%), academic councillors, employed pharmacists and hospital pharmacists.<\/p>\n

The fields of activity of the participants in the last five years cover all parts of the interdisciplinary subject of pharmacy. A large proportion of participants are or were active in Pharmaceutical Chemistry (21.4%), Pharmaceutical Technology (19.7%), followed by activities in Pharmaceutical Biology (12.0%), Medicinal Chemistry (12.0%), Clinical Pharmacy (10.3%), as well as Pharmacology and Toxicology (10.3%) and History of Pharmacy (2.6%) (Fig. 3). Other (12.0%) included drug information, pharmaceutical analytics and biotechnology, and publication support\/systematic literature review.<\/p>\n\n\t\t